Procedure Guide
Indications (AHA Guidelines)
LKH 6-16 hrs meeting DAWN/DEFUSE-3 criteria (LOE I)
DEFUSE-3: NIHSS >=6, RAPID core <70 mL, mismatch ratio >1.8 and volume >15 mL
Consider for LKH 16-24 hrs meeting DAWN criteria (LOE IIa)
Consider for M2, M3, ACA, and posterior circulation (LOE IIb)
Consider for extended criteria, e.g., mRS >1, NIHSS <6, ASPECTS <6 (LOE IIb)
Contraindications
Generally, the opposite of above including onset of symptoms >24 hrs ago, large core infarct due to risk of hemorrhagic conversation, small vessel occlusion or unfavorable anatomy.
Efficacy and alternatives
Generally, endovascular intervention is superior to best supportive medical therapy in appropriately selected patients regardless of whether they were eligible for tPA with number needed to treat of 2-3 across trials.
HERMES meta-analysis of major trials: TICI 2b/3 in 71% of patients with modern devices with 67% achieving a mRS of 0-2.
Aspiration thrombectomy is faster (~11 min) and cheaper (~$4500-5000) relative to stent-retriever with similar TICI outcomes in COMPASS, ADAPT FAST, ASTER, and PROMISE trials
Thrombectomy alone with Solitaire stent-retrievers non-inferior to thrombectomy + tPA (0.9 mg/kg) in SWIFT DIRECT trial, but mRS 0-2 in 57 v 65%, reperfusion in 91 vs 96%, and ICH in 2 vs 3%
No difference in 90d neurologic outcomes if patient in rural area sent to nearly stroke center vs thrombectomy capable referral center in RACECAT trial
SELECT2 RCT: medical care vs thrombectomy for major stroke (ICA or M1), all cause mortality 38.4 v 41.5%, symptomatic ICH 0.6% v 1.1%
ANGEL-ASPECT RCT: medical care vs thrombectomy for major stroke (ICA or M1), mRS score 0-2 30.0% v 11.6%, symptomatic ICH 6.1% v 2.7%
Pre-procedure care
NIHSS assessment (0-42): >=9 in 0-3 hrs of symptom onset or >7 3-6 hrs is suggestive of a large vessel occlusion (LVO)
Mild impairment (<5), moderate (5-14), severe (15-24), very severe (>25)
Can attempt to localize based on symptoms and ask about handedness
Non-contrast head CT with ASPECTS
<=7 associated with worse functional outcomes at 3 mo and symptomatic hemorrhage
Guidelines recommend ASPECTS >=6 for intervention
CTA head and neck vs CT perfusion, both likely sufficient but CTP can provide additional valuable information re mismatch and infarct core.
Infarct core: elevated Tmax (>6s) and low CBF (<30%)
Pneumbra: elevated Tmax (>6s) volume - infarct core
Mean transit time (MTT) = CBV/CBF
Good for thrombectomy = ischemic core <70mL, mismatch ratio >1.8, mismatch volume >15mL
IV tPA or TNK if candidate
TNK (0.25 mg/kg) + thrombectomy superior to tPA (0.9 mg/kg) + thrombectomy in terms of more recanalizations, cost (cheaper by ~$2400), and single bolus rather than bolus + drip in EXTEND-IA TNK trial
Absolute contraindications: head trauma/surgery/stroke in last 3 mo, history of intracranial bleed/cancer/AVM/aneurysm, BP>185/110, Plts<100K, Heparin w/in 48hrs, Warfarin + INR >1.7, active internal bleed
Relative contraindications: seizure at onset, surgery within 2wks, GI/GU bleed within 3wks, pregnant
procedure
Obtain access, often CFA with alternatives including radial and direct carotid access.
If CFA access with tortuous iliacs, consider longer sheath
Radial limited to 5-6 Fr sheath
Direct carotid access, often short 6 Fr sheath. Should be closest to clavicle possible. Suture sheath in place and consider GA to avoid dislodgement. Can use Y-adaptor if plan for multiple exchanges.
Select the ICA with 5 Fr catheter (e.g. Vert) and perform cerebral angiography in AP and lateral projections.
Perform thrombectomy - many techniques with many variations
Most techniques are slight variation on similar principles and tools, generally a large sheath or balloon guide catheter into the parent vessel (e.g. cervical ICA), aspiration catheter, microwire, microcatheter, +/- stent-retriever device
Some advocate for trying aspiration alone first since faster and cheaper (ADAPT technique) with stent-retriever based techniques as back up
If using stent-retriever, retrieval force directly related to degree of integration via proper positioning, pushing out closed cell stents, allow 5-7 minutes for integration
Harder to retrieve with longer dwell time, multiple passes, and high fibrin content
Higher risk of thrombus shearing with small aspiration catheter
Distal to M2 and PCA can be challenging with ischemia risk from catheter being occlusive and shearing small perforators, particularly distal superior MCA branches along frontal operculum
ADAPT FAST technique
Place balloon guide catheter or large sheath into parent vessel
Advance triaxial system but AVOID distal passage
Remove microwire and microcatheter
Slight negative pressure on aspiration catheter with 50 mL syringe until absence of backflow
Inflate BGC if using, advance aspiration catheter slight forward and then slowly withdraw under forceful negative aspiration
E.g. default Einstein approach: 8F groin sheath, 4F Berenstein cath and glidewire advantage, Neuro Max sheath, Penumbra 68, Penumbra 3 max, Marksman cath, fathom 0.016 vs synchro 2 0.014
Balloon Guide/ Stent-retriever
Advance balloon guide catheter (e.g., Cello, Merci, or FlowGate 2)
Attached RHV with side port, flush catheter, and prep balloon
Good to use 1 cc syringe for inflation with 50/50 contrast to not over inflate and damage the vessel
Attach two 60 mL syringes for negative aspiration
Advance microwire (e.g. synchro 2) and microcatheter (e.g. velocity) beyond clot with gentle puff to confirm
Advance and unsheath stent-retriever device andallow to integrate in clot 5-7 min
Retriever device and microcatheter as a unit into the guiding catheter under constant aspiration until good flow reversal
*DO NOT perform >3xs in same vessel*
Solumbra technique
Advance large sheath into cervical internal carotid
Neuron Max may be superior in terms of distal softness and proximal support vs Cook Shuttle, Terumo Destination, Stryker AXS)
Advance distal aspiration catheter, microcatheter, and microwire to clot as above and deploy stent-retriever
Advance aspiration catheter under suction to clot until drip rates slows in tubing
Remove stent-retriever and aspiration catheter as single unit into cervical sheath
CAPTIVE technique
Advance large sheath into cervical ICA followed by triaxial system as above
Advance stent-retriever but turn on aspiration catheter prior to deployment
Remove microcatheter and advance aspiration catheter until drip rate slows in tubing (holding clot “captive”)
Remove stent-retriever and aspiration catheter as single unit into cervical sheath
TRAP/ARTS technique
Advance balloon guide catheter into ICA
Advance triaxial system to clot as above and deploy stent-retriever using forward tension technique
Remove microcatheter and inflate balloon guide catheter balloon
Initiate aspiration catheter during withdrawal of retriever until there’s resistance on the retriever wire suggesting the clot is “trapped”
Remove stent-retriever and aspiration catheter as single unit while aspirating through the balloon guide catheter
SAVE technique
Deploy ⅔ of stent-retriever distal to clot using the active push deployment technique
Advance aspiration catheter to edge of clot and starting aspiration until wedged
Switch aspiration to guide catheter while maintaining vacuum on aspiration catheter with a syringe
Remove stent-retriever and aspiration catheter as single unit while aspirating through the guide catheter
GUARD technique
Advance 6 Fr flexible large bore guide sheath (e.g. Neuro Max) into distal petrocavernous ICA
Adjunctive DAC aspiration and stent-retriever similar to above
Can give IA rt-PA <10 mg for distal fragments even after IV rt-PA. IA GPIIb/IIIa inhibitors may also be safe in a small series.
Refractory cases (8.7% US cohort, 14.6% Korean cohort), e.g., intracranial dissection, refractory clot, or underlying significant atherosclerotic stenosis
IA GPIIb/IIIa inhibitor or primary stenting likely ideal, no difference in treatment failure (NW experience)
Angioplasty alone tended to have worse outcomes and lead to stenting anyways
Completion angiography to assess thrombolysis in cerebral infarction (TICI) scale
Grade 0 (no perfusion), 1 (minimal perfusion), 2A (<2/3 filling of vascular territory), 2B (complete filling but delayed), 3 (complete perfusion)
+/- Adjunctive carotid artery stenting or PFO closure
PFO/ASD closure recommended for ASD or 2nd cryptogenic stroke with PFO, otherwise debated, mixed results w/ RTCs (CLOSURE 1, PC, RESPECT trials). Guidelines generally recommend medical management.
Obtain hemostasis (can use closure devices for carotid access)
Complications
ICH, vascular injury, distal emboli, access site complication (bleeding, infection)
E.g. SELECT2 trial had complications in 18.5% (5.6% dissection, 3.9% vessel perforation, 6.2% vasospasm)
Post-procedure care & Follow Up
Non-contrast CT head, ideally dual energy to rule out ICH
Close neurologic monitoring for complications: herniation from mass effect (peaks @ 3-4d), hemorrhagic conversation (greater risk w/ larger infarct), SIADH, depression
Workup for stroke etiology (below for all strokes)
30% atherosclerosis, dissection, Takayasu arteritis, Giant cell arteritis, fibromuscular dysplasia, Moyamoya;
20% lacunar lipohyalinosis 2/2 HTN
20% cardiogenic (AFib/Flutter, rheumatic valve dx, prosthetic valve, endocarditis, atrial myxoma, papillary fibroelastoma, DVT + PFO/ASD (“paradoxical stroke”), LV aneurysm, sick sinus syndrome, DCM)
12% hemorrhagic
Other: sickle cell disease, polycythemia vera, essential thrombocytosis, HIT, hereditary coagulopathy
Risk factor modification: BP and glucose control, anticoagulation if cardioembolic, otherwise aspirin (81mg) OR clopidogrel (75mg) (DAPT only beneficial for those w/out CYP2C19 LoF alleles or stenting); atorvastatin 80mg regardless of cholesterol (SPARCL trial), stop smoking, exercise; Mediterranean diet, maybe fish oil)
Additional Resources
Decision Aid for Patients and Consent
Backtable Articles and Podcasts on Stroke and Stent Retriever
Multi-Society Practice Parameter for Endovascular Management of Strokes